UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.113

Sortiert nach

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

Antiviral research, 2012-04, Vol.94 (1), p.103-110

2012

Volltextzugriff (PDF)

Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme

Antiviral research, 2011-09, Vol.91 (3), p.288-291

2011

Volltextzugriff (PDF)

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice

Antiviral research, 2010-10, Vol.88 (1), p.38-44

2010

Volltextzugriff (PDF)

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

Antiviral research, 2010-12, Vol.88 (3), p.276-280

2010

Volltextzugriff (PDF)

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Antiviral research, 2021-11, Vol.195, p.105180-105180, Article 105180

2021

Volltextzugriff (PDF)

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

Antimicrobial Agents and Chemotherapy, 2001-04, Vol.45 (4), p.1162-1167

2001

Volltextzugriff (PDF)

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice

Antiviral research, 2011-04, Vol.90 (1), p.17-21

2011

Volltextzugriff (PDF)

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

Antiviral research, 2017-01, Vol.137, p.14-22

2017

Volltextzugriff (PDF)

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Journal of medicinal chemistry, 2000-09, Vol.43 (19), p.3482-3486

2000

Volltextzugriff (PDF)

Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases

European journal of medicinal chemistry, 2024-01, Vol.264, p.115991-115991, Article 115991

2024

Volltextzugriff (PDF)

Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors

Bioorganic & medicinal chemistry, 2022-11, Vol.74, p.117034-117034, Article 117034

2022

Volltextzugriff (PDF)

Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase

The Journal of biological chemistry, 2017-09, Vol.292 (38), p.15907-15915

2017

Volltextzugriff (PDF)

Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity

Journal of medicinal chemistry, 2001-12, Vol.44 (25), p.4379-4392

2001

Volltextzugriff (PDF)

Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon

Bioorganic & medicinal chemistry, 2022-11, Vol.73, p.117035-117035, Article 117035

2022

Volltextzugriff (PDF)

In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

Antimicrobial Agents and Chemotherapy, 2001-03, Vol.45 (3), p.749-757

2001

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study

Allergy (Copenhagen), 2016-12, Vol.71 (12), p.1676-1683

2016

Volltextzugriff (PDF)

Effectiveness of the Guidelines for the Non-Operative Management of Knee Osteoarthritis

Archives of bone and joint surgery, 2021-07, Vol.9 (4), p.472-474

2021

Volltextzugriff (PDF)

Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates

International immunopharmacology, 2003-04, Vol.3 (4), p.541-548

2003

Volltextzugriff (PDF)

Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro- N-Acetyl Neuraminic Acid

Journal of molecular biology, 1993, Vol.232 (4), p.1069-1083

1993

Volltextzugriff (PDF)

Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design

Journal of medicinal chemistry, 1997-12, Vol.40 (25), p.4030-4052

1997

Volltextzugriff (PDF)

Potent Inhibition of Influenza Sialidase by a Benzoic Acid Containing a 2-Pyrrolidinone Substituent

Journal of medicinal chemistry, 1999-07, Vol.42 (13), p.2332-2343

1999

Volltextzugriff (PDF)

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201

Antiviral research, 2001-09, Vol.51 (3), p.179-187

2001

Volltextzugriff (PDF)

Need for appropriate hospital attire in orthopedic patients

Apollo medicine, 2021-04, Vol.18 (2), p.93-98

2021

Volltextzugriff (PDF)

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

Bioorganic & medicinal chemistry, 1999-11, Vol.7 (11), p.2487-2497

1999

Volltextzugriff (PDF)

Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo

Antimicrobial Agents and Chemotherapy, 2004-05, Vol.48 (5), p.1495-1502

2004

Volltextzugriff (PDF)

1 – 25 von 2.113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.598)
Mit Volltextzugriff
(1.883)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.158)
Life Sciences & Biomedicine
(519)
Physical Sciences
(429)
Technology
(342)
Humans
(284)
Physics
(235)
Chemistry
(181)
Materials Science
(169)
Biological And Medical Sciences
(159)
Animals
(143)
Male
(142)
Exact Sciences And Technology
(139)
Female
(128)
Engineering
(121)
Materials Science, Multidisciplinary
(120)
Physics, Applied
(114)
Medical Sciences
(102)
Physics, Condensed Matter
(98)
Pharmacology & Pharmacy
(95)
Biochemistry & Molecular Biology
(88)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(23)

Menü

Weitere Dienste

Einstellungen

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases

Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors

Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase

Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity

Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon

In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study

Effectiveness of the Guidelines for the Non-Operative Management of Knee Osteoarthritis

Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates

Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro- N-Acetyl Neuraminic Acid

Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design

Potent Inhibition of Influenza Sialidase by a Benzoic Acid Containing a 2-Pyrrolidinone Substituent

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201

Need for appropriate hospital attire in orthopedic patients

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo

Suchergebnisse filtern